Key Updates in the 2025 Spanish Asthma Guidelines (GEMA 5.5).
作者信息
Almonacid Carlos, Blanco Marina, Ferreira Jorge, García Gabriel, Morete Ana, Quirce Santiago, Soto-Campos Gregorio, Plaza Vicente
机构信息
Hospital Puerta de Hierro Majadahonda, Madrid, Spain.
Complejo Hospitalario Universitario, A Coruña, Spain.
出版信息
Open Respir Arch. 2025 Jun 9;7(3):100453. doi: 10.1016/j.opresp.2025.100453. eCollection 2025 Jul-Sep.
Abstract
摘要
相似文献
1
Key Updates in the 2025 Spanish Asthma Guidelines (GEMA 5.5).《2025年西班牙哮喘指南（GEMA 5.5）》的关键更新内容。
Open Respir Arch. 2025 Jun 9;7(3):100453. doi: 10.1016/j.opresp.2025.100453. eCollection 2025 Jul-Sep.
2
3
Consensus on the Asthma-COPD Overlap Syndrome (ACOS) Between the Spanish COPD Guidelines (GesEPOC) and the Spanish Guidelines on the Management of Asthma (GEMA).西班牙慢性阻塞性肺疾病指南（GesEPOC）与西班牙哮喘管理指南（GEMA）关于哮喘-慢性阻塞性肺疾病重叠综合征（ACOS）的共识。
Arch Bronconeumol. 2017 Aug;53(8):443-449. doi: 10.1016/j.arbres.2017.04.002. Epub 2017 May 8.
4
Factors associated with severe uncontrolled asthma and the perception of control by physicians and patients.与严重未控制哮喘相关的因素以及医生和患者对控制的认知
Arch Bronconeumol. 2014 Sep;50(9):384-91. doi: 10.1016/j.arbres.2014.03.002. Epub 2014 Apr 26.
5
The integration of geographic methods and ecological momentary assessment in public health research: A systematic review of methods and applications.地理方法与生态瞬时评估在公共卫生研究中的整合：方法与应用的系统评价。
Soc Sci Med. 2024 Aug;354:117075. doi: 10.1016/j.socscimed.2024.117075. Epub 2024 Jun 28.
6
GEMA 5.3. Spanish Guideline on the Management of Asthma.GEMA 5.3. 《西班牙哮喘管理指南》。
Open Respir Arch. 2023 Sep 19;5(4):100277. doi: 10.1016/j.opresp.2023.100277. eCollection 2023 Oct-Dec.
7
Spanish Asthma Management Guidelines (GEMA) VERSION 5.1. Highlights and Controversies.《西班牙哮喘管理指南》（GEMA）第5.1版。要点与争议。
Arch Bronconeumol. 2022 Feb;58(2):150-158. doi: 10.1016/j.arbres.2021.05.010. Epub 2021 May 26.
8
Highlights of the Spanish Asthma Guidelines (GEMA), version 5.0.《西班牙哮喘指南》（GEMA）第5.0版要点
Arch Bronconeumol (Engl Ed). 2021 Jan;57(1):11-12. doi: 10.1016/j.arbres.2020.10.003. Epub 2020 Oct 22.
9
Obsolete anti-pneumococcal vaccination recommendations in the spanish guidelines for the management of asthma (GEMA 4.0): The authors reply.西班牙哮喘管理指南（GEMA 4.0）中过时的抗肺炎球菌疫苗接种建议：作者回复。
Arch Bronconeumol. 2016 Aug;52(8):449. doi: 10.1016/j.arbres.2016.03.011. Epub 2016 Apr 29.
10
[Translated article] Spanish Asthma Management Guidelines (GEMA) v.5.1. Highlights and Controversies.[翻译文章] 《西班牙哮喘管理指南》（GEMA）第5.1版。要点与争议。
Arch Bronconeumol. 2022 Feb;58(2):T150-T158. doi: 10.1016/j.arbres.2021.05.032. Epub 2022 Feb 14.
本文引用的文献
1
Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps.特泽佩umab用于患有严重慢性鼻窦炎伴鼻息肉的成人患者。
N Engl J Med. 2025 Mar 27;392(12):1178-1188. doi: 10.1056/NEJMoa2414482. Epub 2025 Mar 1.
2
Efficacy and safety of twice per year depemokimab in chronic rhinosinusitis with nasal polyps (ANCHOR-1 and ANCHOR-2): phase 3, randomised, double-blind, parallel trials.每年两次注射度匹莫单抗治疗鼻息肉型慢性鼻-鼻窦炎的疗效和安全性（ANCHOR-1和ANCHOR-2）：3期随机双盲平行试验
Lancet. 2025 Mar 15;405(10482):911-926. doi: 10.1016/S0140-6736(25)00197-7. Epub 2025 Mar 1.
3
Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial.使用贝那利珠单抗治疗哮喘和慢性阻塞性肺疾病的嗜酸性粒细胞性加重（ABRA）：一项双盲、双模拟、活性安慰剂对照的随机试验。
Lancet Respir Med. 2025 Jan;13(1):59-68. doi: 10.1016/S2213-2600(24)00299-6. Epub 2024 Nov 29.
4
Efficacy and safety of benralizumab in eosinophilic granulomatosis with polyangiitis: A meta-analysis of eight studies.贝那利珠单抗治疗嗜酸性肉芽肿性多血管炎的疗效与安全性：八项研究的荟萃分析
Eur J Clin Invest. 2025 Feb;55(2):e14333. doi: 10.1111/eci.14333. Epub 2024 Oct 10.
5
Once or consecutive administration of inhaled salbutamol in children with acute asthma exacerbation: Is an additional dose beneficial?儿童急性哮喘加重时单次或连续吸入沙丁胺醇：额外剂量有益吗？
Pediatr Pulmonol. 2024 Dec;59(12):3190-3196. doi: 10.1002/ppul.27171. Epub 2024 Jul 9.
6
Spanish Consensus on Remission in Asthma (REMAS).西班牙哮喘缓解共识（REMAS）。
Arch Bronconeumol. 2024 Aug;60(8):503-509. doi: 10.1016/j.arbres.2024.04.002. Epub 2024 Apr 23.
7
Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis/mycoses.修订的 ISHAM-ABPA 工作组临床实践指南，用于诊断、分类和治疗变应性支气管肺曲霉病/真菌病。
Eur Respir J. 2024 Apr 4;63(4). doi: 10.1183/13993003.00061-2024. Print 2024 Apr.
8
Long-Term Effectiveness of Benralizumab in Eosinophilic Granulomatosis With Polyangiitis.贝那利珠单抗治疗嗜酸性肉芽肿性多血管炎的长期疗效
J Allergy Clin Immunol Pract. 2024 Mar;12(3):724-732. doi: 10.1016/j.jaip.2024.01.006. Epub 2024 Jan 9.
9
Relationship Between Birth Weight and Asthma Diagnosis: A Cross-Sectional Survey Study Based on the National Survey of Children's Health in the U.S.出生体重与哮喘诊断之间的关系：基于美国国家儿童健康调查的横断面调查研究
BMJ Open. 2023 Dec 1;13(12):e076884. doi: 10.1136/bmjopen-2023-076884.
10
Association Between T2-related Comorbidities and Effectiveness of Biologics in Severe Asthma.T2 相关共病与生物制剂治疗重度哮喘疗效的关系。
Am J Respir Crit Care Med. 2024 Feb 1;209(3):262-272. doi: 10.1164/rccm.202305-0808OC.
Zotero 插件